Login
$ARKR
$4.38 -$0.13 (2.88%) Live

Company Executives

Officer Age Joined 2025 pay Source
Michael Weinstein Also a director
Chairman & CEO
Title from the Form 4 dated Sep 24, 2026
82 Not stated $825,000
Jennifer Jordan
Co-Chief Operating Officer
63 1984 Not reported
Samuel Weinstein
Co-Chief Operating Officer
31 Not stated $193,269
Anthony J. Sirica Also a director
Executive officer
62 Not stated $550,000

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
4 of 4
stated in the proxy; 2 not stated
Average tenure
20.8 years
from year joined
CEO also chairs the board
Yes
Michael Weinstein
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Weinstein
82 1983
43 years
Not stated None stated None stated Paid as CEO
Anthony J. Sirica
62 2018
8 years
Not stated None stated None stated Not stated
Marcia Allen
75 2003
23 years
Independent
Compensation Committee Audit Committee Nominating and Corporate Governance Committee
INmune Bio, Inc. $47,500
Jessica Kates
47 2022
4 years
Independent
Audit Committee
None stated $46,000
Bruce R. Lewin
78 2000
26 years
Independent
Audit Committee · Chair Nominating and Corporate Governance Committee
None stated $61,000
Stephen Novick
85 2005
21 years
Independent
Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair
None stated $41,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Jan 26, 2026
Mr. Pascal
resigned as a director and Chief Operating Officer of the Company, effective April 30, 2024
$500,000
three-year term

Three-year Pascal Advisory Agreement to provide general operational advice to the Company for an annual fee.

Mr. Pascal
resigned as a director and Chief Operating Officer of the Company, effective April 30, 2024
Amount not stated
term of the Pascal Advisory Agreement

Company continues to provide health insurance to Mr. Pascal for the term of the advisory agreement.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support